DFDA

Ivermectin

Treatment for Ascariasis

Typical Dosage: 150-200 mcg/kg oral single dose

Effectiveness
95%
Safety Score
70%
Clinical Trials
4
Participants
1.5M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
150-200 mcg/kg oral single dose
Time to Effect
1-3 days
Treatment Duration
Single dose
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$600
Side Effect Mgmt:$0
Total Annual:$630
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.06
Outcome-Based Costs
Cost per Responder
$30.61
Cost per Remission
$31.58
Prescription Access Economics
Annual Societal Loss per Patient
$120
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$35/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$30/year
Potential OTC Price
$15/year
Estimated if OTC available
Early Treatment Benefit
+0.01 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Ivermectin Outcomes

for Ascariasis

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+98%
Remission Rate
+95%
Common Side Effects
Dizziness
+5%
Nausea
+4%
Abdominal pain
+3%

Sources:

nih.gov
cochrane.org
cochranelibrary.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
4 completed trials for Ivermectin in Ascariasis

Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC

NCT06184399COMPLETEDPHASE2
View Study
260 participants
INTERVENTIONAL
Chake Chake, Tanzania
Started: Jun 5, 2024

Efficacy and Safety of MOX/ALB Co-administration

NCT04726969COMPLETEDPHASE3
View Study
255 participants
INTERVENTIONAL
Abidjan, Côte d’Ivoire
Started: Jun 15, 2021

Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration

NCT04700423COMPLETEDPHASE2, PHASE3
View Study
536 participants
INTERVENTIONAL
Chake Chake, Tanzania
Started: Mar 1, 2021

Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections

NCT00207753COMPLETEDNA
View Study
550 participants
INTERVENTIONAL
Poptún, Guatemala
Started: Feb 1, 2005